Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Apr 7:2019:5083624.
doi: 10.1155/2019/5083624. eCollection 2019.

Cardiac and Systemic Thrombus Caused by Drug Abuse

John Eliveha  1 , Shravani Vindhyal  1 , Mohinder Vindhyal  1
Affiliations
Case Reports

Cardiac and Systemic Thrombus Caused by Drug Abuse

John Eliveha et al. Case Rep Cardiol. .

Abstract

Drug abuse is an increasing concern all over the world especially in the United States. Methamphetamine have been well established to cause elevated body temperature, irregular heartbeat, seizures, and heart disease. We present a case of ventricular thrombus with systemic emboli in a patient with dilated cardiomyopathy after methamphetamine use.

PubMed Disclaimer

Figures

Figure 1
Figure 1
EKG showing nonspecific ST-T wave changes.
Figure 2
Figure 2
CT angiogram showing a massive AAA thrombus beyond the renal arteries.
Figure 3
Figure 3
CT angiogram reconstruct showing large segmental aortic occlusions.
Figure 4
Figure 4
Parasternal long axis view showing LV thrombus. LA: left atrium; AO: aorta; RV: right ventricle; LV: left ventricle.
Figure 5
Figure 5
Parasternal short axis view. Mid to apical segment showing LV thrombus. LV: left ventricle.
Figure 6
Figure 6
Apical four-chamber view showing LV thrombus. LA: left atrium; RA: right atrium; RV: right ventricle; LV: left ventricle.
See this image and copyright information in PMC

References

    1. Won S., Hong R. A., Shohet R. V., Seto T. B., Parikh N. I. Methamphetamine-associated cardiomyopathy. Clinical Cardiology. 2013;36(12):737–742. doi: 10.1002/clc.22195. - DOI - PMC - PubMed
    1. Schürer S., Klingel K., Sandri M., et al. Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy. JACC: Heart Failure. 2017;5(6):435–445. doi: 10.1016/j.jchf.2017.02.017. - DOI - PubMed
    1. Islam M. N., Kuroki H., Hongcheng B., et al. Cardiac lesions and their reversibility after long term administration of methamphetamine. Forensic Science International. 1995;75(1):29–43. doi: 10.1016/0379-0738(95)01765-B. - DOI - PubMed
    1. Nishida N., Ikeda N., Kudo K., Esaki R. Sudden unexpected death of a methamphetamine abuser with cardiopulmonary abnormalities. Medicine, Science and the Law. 2003;43(3):267–271. doi: 10.1258/rsmmsl.43.3.267. - DOI - PubMed
    1. Kaye S., McKetin R. National Drug and Alcohol Research Centre (Australia) Cardiotoxicity associated with methamphetamine use and signs of cardiovascular pathology among methamphetamine users. Sydney: NDARC; 2005.

Publication types

LinkOut - more resources